• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunocytochemical and lectin histochemical studies of plaques and tangles in Down's syndrome patients at different ages.

作者信息

Mann D M, Brown A, Wilks D P, Davies C A

机构信息

Department of Pathology, Manchester University, Medical School, Gt. Britain.

出版信息

Prog Clin Biol Res. 1989;317:849-56.

PMID:2532371
Abstract

The presence of numerous senile plaques (SP) and neurofibrillary tangles (NFT) within association areas of the neocortex and within the hippocampus and amygdala, is generally regarded as providing the histopathological hallmarks of Alzheimer's disease (AD) (Mann, 1985). Similar pathological changes, to those of AD, are seen in the brains of nearly all persons with Down's syndrome (DS) who live beyond 40 years of age, though such features are only rarely seen before 20 years of age (Mann, 1988). Because of this similarity between AD and DS at middle age, DS has been considered (Mann, 1988) to provide a useful model for the pathological process of AD. Hence a study of DS patients at different ages (and in all of whom the pathological changes typical of AD would have been expected had they lived long enough) can provide important data concerning the time course of the acquisition and the morphological and biochemical genesis of SP and NFT in DS, with obvious implications as to the changes of AD itself. In this study, the brains of 24 patients dying, between the ages of 13 and 65 years, with DS have been examined for the presence and the morphological appearance of SP and NFT using various markers for structural or biochemical components known, from previous work on AD (Ihara, 1988; Ihara et al., 1986; Davies et al., 1988; Mann et al., 1988) to be associated with SP and NFT.

摘要

相似文献

1
Immunocytochemical and lectin histochemical studies of plaques and tangles in Down's syndrome patients at different ages.
Prog Clin Biol Res. 1989;317:849-56.
2
Histopathological studies on senile plaques in brains of patients with Down's syndrome.
Kobe J Med Sci. 1990 Dec;36(5-6):153-71.
3
Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21).唐氏综合征(21三体综合征)中阿尔茨海默病表型表达的性别差异。
Neuroreport. 1994 Jun 27;5(11):1393-6.
4
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.唐氏综合征中异质性淀粉样β肽和载脂蛋白E的沉积顺序:对淀粉样斑块形成初始事件的影响。
Neurobiol Dis. 1996 Feb;3(1):16-32. doi: 10.1006/nbdi.1996.0003.
5
Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.阿尔茨海默病和年轻唐氏综合征大脑中β淀粉样蛋白11-40/42肽沉积的特征:N端截短的β淀粉样蛋白物种在阿尔茨海默病发病机制中的意义。
Acta Neuropathol. 2006 Aug;112(2):163-74. doi: 10.1007/s00401-006-0077-5. Epub 2006 Jun 1.
6
Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.唐氏综合征患者大脑中β-淀粉样蛋白免疫反应性早期斑块病变的证据。
Lab Invest. 1989 Jul;61(1):133-7.
7
An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques.
Neuropathol Appl Neurobiol. 1989 Jul-Aug;15(4):317-29. doi: 10.1111/j.1365-2990.1989.tb01232.x.
8
The amygdala in Down's syndrome and familial Alzheimer's disease: four clinicopathological case reports.唐氏综合征和家族性阿尔茨海默病中的杏仁核:四例临床病理病例报告。
Biol Psychiatry. 1991 Jul 1;30(1):92-106. doi: 10.1016/0006-3223(91)90075-w.
9
[Cerebral degeneration in Down's syndrome].
Folia Psychiatr Neurol Jpn. 1979;33(1):81-96.
10
Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.唐氏综合征患者杏仁核中斑块和神经原纤维缠结的抗原谱:与阿尔茨海默病的比较。
Brain Res. 1990 Dec 24;537(1-2):102-8. doi: 10.1016/0006-8993(90)90345-c.

引用本文的文献

1
Amyloid beta: structure, biology and structure-based therapeutic development.淀粉样β:结构、生物学和基于结构的治疗开发。
Acta Pharmacol Sin. 2017 Sep;38(9):1205-1235. doi: 10.1038/aps.2017.28. Epub 2017 Jul 17.
2
Olfaction in People with Down Syndrome: A Comprehensive Assessment across Four Decades of Age.唐氏综合征患者的嗅觉:跨越四个年龄段的综合评估
PLoS One. 2016 Jan 5;11(1):e0146486. doi: 10.1371/journal.pone.0146486. eCollection 2016.
3
Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain.
氧化还原蛋白质组学分析以解析阿尔茨海默病样神经退行性变的神经生物学:唐氏综合征与阿尔茨海默病大脑的重叠
Biochem J. 2014 Oct 15;463(2):177-89. doi: 10.1042/BJ20140772.
4
Combination therapy prevents amyloid-dependent and -independent structural changes.联合治疗可预防淀粉样依赖和非依赖的结构变化。
Neurobiol Aging. 2012 Jul;33(7):1273-83. doi: 10.1016/j.neurobiolaging.2010.12.007. Epub 2011 Jan 22.